ZAP-70 inhibitors (BioFocus/Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameZAP-70 inhibitors (BioFocus/Roche)
Drug Alias Nameimmunosuppressants (BioFocus/Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ZAP-70 inhibitors
TargetsTyrosine-protein kinase ZAP-70
Therapy Area/IndicationsAutoimmune DiseasesImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioFocus DPI
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioFocus DPIRoche Products Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A